Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure: New Opportunities to Improve Patient Outcomes
October 08, 2025
In this symposium, Chair Dr. Mathew Maurer, and faculty members Dr. Noel Dasgupta, Dr. Omar Abou Ezzeddine, and Dr. Frederick Ruberg, will explain best practices for screening and diagnosing ATTR-CM in patients with concomitant HF, describe the treatment landscape, and, through case presentation, discuss practical considerations in management.
CME 1.25 Credits In-Progress
Clinical Clues, Diagnostic Pearls, and a Changing Therapeutic Landscape: Optimizing the Management of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in Patients with Heart Failure
July 30, 2025
In this symposium, three experts in ATTRCM (Dr. Mathew Maurer, Dr. Sarah Cuddy, and Dr. Melissa Lyle) will explain best practices for identifying and diagnosing ATTR-CM in patients with concomitant HF, describe the evidence for current ATTR-CM therapies and, through case presentation, discuss practical considerations in management.
CME 1.00 Credits In-Progress
Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk
July 29, 2025
In this symposium, attendees will be provided with best practices by a multidisciplinary faculty on the prevention of hyperkalemia, identification of patients at risk for hyperkalemia, the importance of maintaining HF patients on RAASis and preferably at target doses, recent clinical evidence with novel potassium binders, and strategies for effective communication with patients.
CME 1.00 Credits In-Progress
Improving Pump Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Challenges and Opportunities
March 23, 2022
In this program, HF experts will provide insights into mechanisms and clinical evidence for improving myocardial contractility, and emphasize the need for a more personalized treatment of HFrEF to optimize patient outcomes.
No Credit Available
SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice
March 19, 2022
Information on best uses of SGLT2 inhibitors for patients with HF will be disseminated through lecture, interactive case presentation, panel discussion, and question-and-answer with experts.
No Credit Available
Managing the Heart Failure Patient with Reduced Ejection Fraction: New Perspectives and Emerging Evidence
November 13, 2021
In this program, HF experts will provide insights into mechanisms for improving myocardial contractility and clinical evidence and emphasize the need for a more personalized treatment of HFrEF.
No Credit Available
Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes
November 04, 2021
This program will address challenges for interventional cardiologists in using antiplatelet therapy, with the overarching focus on balancing the need to reduce ischemic risk and lower bleeding risk.
No Credit Available
Cardiovascular Outcome Trials and Expert Consensus Decision Pathways: Interpreting the Evidence with Nonstatin Therapies
May 21, 2019
No Credit Available
CROSSROADS OF CARE: Facing the Challenges of Heart Failure and Diabetes
April 01, 2019
In this symposium, Dr. James Januzzi and Dr. Mikhail Kosiborod will explain the intertwined relationship between diabetes and HF, and interpret safety and effi cacy data, focusing on HF-related outcomes, from studies with diabetes therapies.
No Credit Available
Hyperkalemia and Heart Failure: Recognizing Risks and Exploring Strategies for Improving Outcomes
February 24, 2019
In this program, Dr. Paul Hauptman and Dr. Javed Butler will 1) describe the relationship between RAAS inhibitors, hyperkalemia, and cardiovascular risk, 2) identify goals and treatments for acute, intermediate, and chronic management, and 3) discuss the clinical profi les of, and clinical settings for the use of, new potassium binders.
No Credit Available
LDL-Cholesterol Lowering and Atherosclerotic Cardiovascular Disease Risk Reduction: Exploring the Evidence With Non-Statin Therapy
June 17, 2018
n this program, lipid experts will present, in state-of-the-art lectures and in 'realworld' interactive cases, optimal strategies and provide 'take-home' messages for reducing risk in patients with elevated LDL-C.
No Credit Available
Heart Failure Management: Exploring Best Practices for the Internist
September 26, 2017
Experts Dr. Javed Butler and Dr. James Januzzi provide helpful insights on the topic of Heart Failure and offer best practices on heart failure management.
No Credit Available